Back to Journals » Drug Design, Development and Therapy » Volume 13

Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura

Total article views   HTML views PDF downloads Totals
18,436 Dovepress* 13,626+ 1,676 15,302
PubMed Central* 4,810 1,215 6,025
Totals 18,436 2,891 21,327
*Since 17 April 2019
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar